2-methoxyisobutylisonitrile

Abstract. The search for new radiopharmaceuticals for tumour diagnosis usually proceeds on the basis of rational concepts drawing… Expand

Abstract Technetium-99m 2-methoxyisobutylisonitrile (99mTc-MIBI) has been proposed as a potential tracer in patients with… Expand

Abstract. The success of parathyroid surgery is determined by the identification and removal of all parathyroid tumors… Expand

18Fluorine-fluorodeoxyglucose (FDG) positron-emission tomography (PET) has emerged as a useful method in various fields of… Expand

Whole-body fluorine-18 fluorodeoxyglucose (FDG) positron emission tomography (PET) imaging was performed during the follow-up of… Expand

Hexakis (2-methoxyisobutylisonitrile) technetium-99m (99mTc-MIBI) is a gamma-emitting radiopharmaceutical probe currently in… Expand

We tested the possibility of identifying areas of hibernating myocardium by the combined assessment of perfusion and metabolism… Expand

Scintigraphy using hexakis (2-methoxyisobutylisonitrile) technetium (I) [Tc-MIBI] was performed in a patient with osteosarcoma of… Expand

Myocellular uptake and retention of technetium-99m-hexakis (2-methoxyisobutylisonitrile) (Tc-MIBI), a lipophilic cationic… Expand

Hexakis(2-methoxyisobutylisonitrile) technetium(I) (Tc-MIBI) is representative of a class of 99mTc-based lipophilic cationic… Expand